Downstaging Hepatocellular Carcinoma with Yttrium-90 radioembolization: resection or transplantation?

G M Ettorre; A Laurenzi; G Vennarecci

doi:10.1016/j.ejso.2014.01.017

Downstaging Hepatocellular Carcinoma with Yttrium-90 radioembolization: resection or transplantation?

Eur J Surg Oncol. 2014 Jun;40(6):789-90. doi: 10.1016/j.ejso.2014.01.017. Epub 2014 Feb 15.

Authors

G M Ettorre¹, A Laurenzi², G Vennarecci²

Affiliations

¹ General Surgery and Liver Transplantation, San Camillo Hospital, Circ. ne Gianicolense 87, 00151 Rome, Italy. Electronic address: gmettorre@scamilloforlanini.rm.it.
² General Surgery and Liver Transplantation, San Camillo Hospital, Circ. ne Gianicolense 87, 00151 Rome, Italy.

PMID: 24572481
DOI: 10.1016/j.ejso.2014.01.017

Abstract

Trans Arterial Radio Embolization with Yttrium 90 in the treatment of Hepatocellular Carcinoma is becoming a new interesting tool in the treatment of patients that are considered non resectable and non transplantable. A successful downstaging could improve the number of patients that could benefit from a resection or a liver transplantation, but some points still need to be addressed.

Keywords: Downstaging; HCC; Liver transplantation; Resection; Yttrium 90 radioembolization.

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular / therapy*
Embolization, Therapeutic / methods*
Female
Hepatectomy*
Humans
Liver Neoplasms / therapy*
Liver Transplantation*
Yttrium Radioisotopes / therapeutic use*

Substances

Yttrium Radioisotopes